Palatin Announces FDA Clearance of Ind Application for the Co-Administration of Bremelanotide With Tirzepatide (GLP-1) for the Treatment of Obesity
帕拉汀宣佈美國食品藥品管理局批准了佈雷美拉諾肽與替塞帕肽(GLP-1)聯合給藥治療肥胖的印度申請
Palatin Announces FDA Clearance of Ind Application for the Co-Administration of Bremelanotide With Tirzepatide (GLP-1) for the Treatment of Obesity
帕拉汀宣佈美國食品藥品管理局批准了佈雷美拉諾肽與替塞帕肽(GLP-1)聯合給藥治療肥胖的印度申請
使用瀏覽器的分享功能,分享給你的好友吧